Financial Information
Pharmaceutical Product Development, Inc.
NASD: (PPDI)Sector: Healthcare
Industry: Biotechnology & Drugs
| BRIEF: For the six months ended 30 June 2007, Pharmaceutical Product Development, Inc.'s revenues increased 12 percent to $682.2 million. Net income increased 8 percent to $84.6 million. Revenues reflect an increase in sales from development division and higher sales from reimbursed out-of-pocket sales. Net income was partially offset by an increase in research & development expenses, higher selling, general & administrative expenses and increased depreciation expenses. OFFICERS: Ernest Mario, Chairman of the Board; Fredric Eshelman, Vice Chairman of the Board, Chief Executive Officer; Daniel Darazsdi, Chief Financial Officer; William Sharbaugh, Chief Operating Officer; Paul Covington, Executive Vice President - Development. TRANSFER AGENT: American Stock Transfer Trust Company. Company incorporated in N.C. Direct inquiries to: Director of Investor Relations. |
|
Pharmaceutical Product Development, Inc. 929 North Front Street Wilmington, NC 28401 Phone: +910 558 7585 Fax: +910 558 7056 Sector Name: Healthcare Industry Name: Biotechnology & Drugs Complete Financials: 30 Jun 2007 |
| Latest Earnings Release & 10-Q | Date Filed | Format | Size | |
|---|---|---|---|---|
| Fourth Quarter Financial Results |  |
N/A | ||
| Form 10-Q | May 5, 2009 | 
|
375.0 KB | |
| Latest Annual Report & 10-K | Date Filed | Format | Size | |
| Form 10-K | Feb 24, 2009 |
|
1.3 MB | |
| Latest Proxy Statement | Date Filed | Format | Size | |
| Proxy Statement | Apr 2, 2009 |
|
501.4 KB | |
| Share Related Items | |
|---|---|
| Market Cap. (Mil) $ | 2,682.420 |
| Shares Out (Mil) | 117.909 |
| Float (Mil) | 106.400 |
Data as of Jul 1, 2009.
Mil=Millions
| Ticker | PPDI |
| Exchange | NASDAQ | Price | $21.87 |
| Change | - 0.88 |
| Volume | 1,339,800 |
| 7/2/2009 - 4:08 PM ET | |
